ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

SUP Supreme Plc

128.00
4.00 (3.23%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Supreme Investors - SUP

Supreme Investors - SUP

Share Name Share Symbol Market Stock Type
Supreme Plc SUP London Ordinary Share
  Price Change Price Change % Share Price Last Trade
4.00 3.23% 128.00 16:35:00
Open Price Low Price High Price Close Price Previous Close
124.00 124.00 125.50 128.00 124.00
more quote information »
Industry Sector
SUPPORT SERVICES

Top Investor Posts

Top Posts
Posted at 19/2/2024 11:03 by melloteam
Just to let shareholders and prospective investors know that Supreme (SUP) will be one of the companies discussed on the BASH (Buy, Avoid, Sell, Hold) Panel on tonight's MelloMonday webinar, starting at 5pm.


The programme is as follows:

5:00pm James Ashton, CEO at the Quoted Companies Alliance presents What is the QCA?
5:30pm Company presentation by Poolbeg Pharma
6:00pm Company presentation by Time Finance
6:30pm Trading Update from Duke Royalty
6:50pm BASH Panel with Mark Simpson (SDG) Kevin Taylor (ALU) & Graham Neary (SUP) 

Tickets are still available and if you would like one at half price then enter the code MMTADVFN50.
Posted at 06/1/2024 00:58 by elrico
Supreme plc has swept up Foodiq UK Holdings Ltd for a mere £175,000, a move that veers sharply from the conventional wisdom of finance given the state of Foodiq Holding’s finances. Far from a gamble, this acquisition seems to be a masterstroke in Supreme’s grand design to fortify its standing in the ever-expanding arenas of protein and vitamins, which should help cushion the Company from the throw-away vapes.

Although at first glance, you may think I have gone way too deep into what is a relatively short news item, and for just £175,000, is it really worth it? There is an excellent reason I have dedicated so much effort to this particular acquisition. I sense it will serve as a good thesis for SkinBioTherapeutic’s proposed buy-build acquisitions, which are expected to be accretive, and similar acquisition logic applies.

It should be noted that Foodiq’s financial situation is not looking good. Their net worth has gone into the negative at -£782,624, and they have a substantial net current liability of £1,642,032. However, Supreme’s decision to acquire Foodiq for only £175,000 suggests that they have a strategy that goes beyond just looking at the numbers. Even though Foodiq’s assets cost almost £1.2 million, investors should know that Supreme’s accounts will absorb any losses or liabilities. This means that while the deal may seem sweet, it’s not relatively as straightforward as it appears. Nonetheless, it’s unlikely to threaten Supreme’s cash resources, which will become apparent soon.

Supreme’s acquisition is not just a purchase; it’s a veritable chess move. The prize? A cutting-edge, fully accredited, automated contract manufacturing facility nestled near London. This facility, barely a year and a half old and constructed at a hefty sum of nearly £1.2 million, is a jewel in the crown of Supreme’s manufacturing empire. The increase in wellness manufacturing capacity by a staggering 40% propels Supreme into a new echelon in the competitive protein and vitamin market.

Continue...
Posted at 29/11/2023 12:59 by edmonda
Investor Presentation video recording (Interim Results - Nov 2023)

Link here:

Sandy Chadha (CEO) and Suzanne Smith (CFO) of Supreme plc ran investors through highlights of strong H1 results which included growth in revenue, EBITDA and pre-tax profit. The company upgraded profit guidance for FY24 on the back of a strong start to H2.

Management discussed each business category and highlighted the outstanding performance in Vaping, also touching on proactive measures already being taken in advance of possible legislative action from government. The team also answered investor questions in a wide-ranging Q&A session.

The full video recording is now available, divided into chapters as below:
0:00:31 Vertically integrated platform
0:02:32 Key investment highlights
0:06:08 Financial highlights & Operational summary
0:09:06 Outlook
0:11:20 Vaping
0:12:32 Branded Distribution
0:13:44 Legislation & proactive measures
0:16:02 Wellness & Sports Nutrition
0:17:28 Lighting
0:18:39 Batteries
0:19:46 Financials & Summary
0:25:44 Questions & Answers
Posted at 28/11/2023 11:24 by bathcoup
"Management will be hosting a presentation for investors in relation to the Company's interim results on 28 November 2023 at 2pm BST."

2pm BST!?
Posted at 28/11/2023 10:25 by edmonda
Just a reminder that we are hosting a webinar with Q&A at 2pm today (with Supreme's CEO and CFO) - you can sign up here to register:
Posted at 26/9/2023 07:37 by mammyoko
Good results. Will investors hold their nose and buy?
Posted at 12/9/2023 08:30 by iandippie
Definitely will take a hit and it will be oversold before it recovers. Out for now as I fear this will have no support except from speculative investors.
Posted at 07/7/2023 16:35 by boonboon
Investor presentation hTtps://youtu.be/xH3QrSce0-Y
Posted at 06/7/2023 07:43 by edmonda
Detailed new research report (and reminder of the investor presentation this morning at 11am with Supreme management, sign up here:

"Strong FY23 results backed by vaping acquisitions"

For the year to 31 March 23, Supreme reported revenue of £155.6m, +19%YoY (with H2 revenue rebounding 27%YoY versus H1 +6%YoY), and (adj.) EBITDA of £19.4m, -8%YoY (compared to H1 -19%YoY). Revenue was ahead of our estimate of £150m; (adj.) EBITDA matched our outlook. The Vaping product segment recorded revenue of £76.1m +75%YoY, 49% of total, with 40% of incremental revenue (c.£13m) generated by the acquired Liberty Flights, Cuts Ice and Flavour Core operations. Even excluding the contribution from acquisitions, we estimate that growth was an impressive 45%YoY. Batteries revenue grew 13%YoY to £39.5m, 25% of total. Lighting revenue declined 43%YoY (£15.4m) due to customer overstocking issues, but H2 recovered 50% on H1. Sports Nutrition & Wellness revenue grew 5%YoY (£16.8m), and the Branded Household Goods & Other segment contributed £7.8m of revenue (-17%YoY).

As of 31 March, the Group was (pre-IFRS 16) cash positive (£3.2m), having generated £19.3m in (net) cash from operations, in addition to which the disposal of TJuice yielded £4.0m. £30m in borrowing facilities offers the potential to grasp further suitable M&A opportunities. Consistent with Group policy of a 25% of net profit dividend policy, a dividend of 3p/share is payable for the year.

Supreme has announced a master distributor agreement in the UK for the popular Elf Bar and Lost Mary (QM600) range of disposable vapes across its retail network; we estimate that in FY24 this could add c.£25m in additional revenue and c.£2.0m in (adj.) EBITDA. The brands are owned by Shenzhen iMiracle Technology Co. Ltd., in China, and are some of the most popular disposable vape brands in the US (e.g. the Elf Bar BC5000).

Reflecting the potential impact of the Elf Bar distributor agreement, we have raised our FY24 revenue outlook by 20% to £194.5m, and (adj.) EBITDA outlook by 19% to £25.6m. Our Fair Value increases to 200p/share, indicative of a FY24 EV/EBITDA of 8.7x.

Link to report & audio summary:
Posted at 18/4/2023 21:20 by taursus
Biotechbull

Thanks for the reply. We appear to be largely in agreement! My point about the gross margin goes to the quality of earnings (and hence the multiple investors might pay for those earnings).

Supreme’s highest quality (and highest margin) earnings are from those brands which Supreme owns and for which Supreme manufactures the products predominantly in-house (for instance, 88Vape). Management seems keen to stress during presentations the high proportion of the GP that comes from own manufactured products. The lowest quality earnings (and lowest margin) are from distribution of battery brands, mostly under non-exclusive licences (for instance, for Energizer batteries), or where it just acts as a distributor (for instance, household goods).

Until FY23, the vast majority of Vaping earnings appeared to be at the very top of the margin hierarchy. But a fair portion of the increase in this year’s Vaping sales seems to have come from (Chinese-manufactured, I assume) disposable vapes(Supreme’s own brand(s), third-party brands, or both?), closer to the bottom of the margin hierarchy than the top. And at the same time disposable vapes have attracted increasing controversy because of environmental concerns and fears about increased use by children. The risk of action (through increased regulation, taxes or whatever) against this part of the vaping market therefore appears to be growing, in my view; this doesn’t/won217;t help sentiment towards what many investors, or so I am told, regard as a play on vaping.

Perhaps the margin on disposables could be improved by bringing manufacture in-house, but would in-house manufacture be feasible and more economic? And would reputational risk increase if the only disposable brands sold are Supreme’s own brands?

Those are my concerns.

Your Recent History

Delayed Upgrade Clock